UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020-05, Vol.23 (3), p.510-519

2020

Volltextzugriff (PDF)

Theoretical study of interfacial effects on low-energy electron dynamics in chemically amplified resist processes of photomask fabrication

Japanese Journal of Applied Physics, 2021-08, Vol.60 (8), p.86503

2021

Volltextzugriff (PDF)

Relationship between blurring factors and interfacial effects in chemically amplified resist processes in photomask fabrication

Japanese Journal of Applied Physics, 2021-12, Vol.60 (12), p.126504

2021

Volltextzugriff (PDF)

Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021-07, Vol.24 (4), p.946-958

2021

Volltextzugriff (PDF)

Resist Thickness Dependence of Latent Images in Chemically Amplified Resists Used for Electron Beam Lithography

Journal of Photopolymer Science and Technology, 2021/06/11, Vol.34(1), pp.17-25

2021

Volltextzugriff (PDF)

Theoretical study on trade-off relationships between resolution, line edge roughness, and sensitivity in photomask production by electron beam lithography

Japanese Journal of Applied Physics, 2019-07, Vol.58 (7), p.76501

2019

Volltextzugriff (PDF)

Theoretical study on protected unit fluctuation of chemically amplified resists used for photomask production by electron beam lithography

Japanese Journal of Applied Physics, 2020-01, Vol.59 (1), p.16503

2020

Volltextzugriff (PDF)

Theoretical study on effects of electron thermal energy on sensitization process of chemically amplified electron beam resists-contribution to resist heating effect in electron beam mask writing

Japanese Journal of Applied Physics, 2019-11, Vol.58 (11), p.116503

2019

Volltextzugriff (PDF)

Analysis of mitigating factors for line edge roughness generated during electron beam lithography using machine learning

Japanese Journal of Applied Physics, 2021-07, Vol.60 (7), p.76509

2021

Volltextzugriff (PDF)

Resist thickness dependence of line width roughness of chemically amplified resists used for electron beam lithography

Japanese Journal of Applied Physics, 2020-08, Vol.59 (8), p.86501

2020

Volltextzugriff (PDF)

Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection

PloS one, 2014-07, Vol.9 (7), p.e101902

2014

Volltextzugriff (PDF)

Theoretical study on effects of exposure pattern width on line edge roughness and stochastic defect generation in fabrication of 16-nm-half-pitch line-and-space patterns by electron beam lithography

Japanese Journal of Applied Physics, 2017-11, Vol.56 (11), p.116501

2017

Volltextzugriff (PDF)

Heating effect of the radiation chemistry of polyhydroxystyrene-type chemically amplified resists

Japanese Journal of Applied Physics, 2020-08, Vol.59 (8), p.86506

2020

Volltextzugriff (PDF)

Comparison of S-1–cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials

International journal of clinical oncology, 2020-09, Vol.25 (9), p.1635-1643

2020

Volltextzugriff (PDF)

Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2023-01, Vol.26 (1), p.132-144

2023

Volltextzugriff (PDF)

Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2022-01, Vol.25 (1), p.207-217

2022

Volltextzugriff (PDF)

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019-03, Vol.22 (2), p.344-354

2019

Volltextzugriff (PDF)

Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701

International journal of clinical oncology, 2021-10, Vol.26 (10), p.1871-1880

2021

Volltextzugriff (PDF)

Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-07, Vol.19 (3), p.927-938

2016

Volltextzugriff (PDF)

Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study

International journal of clinical oncology, 2020-04, Vol.25 (4), p.614-621

2020

Volltextzugriff (PDF)

Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020-01, Vol.23 (1), p.143-153

2020

Volltextzugriff (PDF)

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells

Oncotarget, 2014-12, Vol.5 (23), p.11847-11856

2014

Volltextzugriff (PDF)

Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing

PloS one, 2015-05, Vol.10 (5), p.e0121891-e0121891

2015

Volltextzugriff (PDF)

A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma

International journal of clinical oncology, 2017-10, Vol.22 (5), p.905-912

2017

Volltextzugriff (PDF)

A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.383-383

2020

Volltextzugriff (PDF)

1 – 25 von 1.163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(759)
Mit Volltextzugriff
(921)

Publikationsform

Sprache

Englisch
(1.008)
Japanisch
(226)
Koreanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data

Theoretical study of interfacial effects on low-energy electron dynamics in chemically amplified resist processes of photomask fabrication

Relationship between blurring factors and interfacial effects in chemically amplified resist processes in photomask fabrication

Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab

Resist Thickness Dependence of Latent Images in Chemically Amplified Resists Used for Electron Beam Lithography

Theoretical study on trade-off relationships between resolution, line edge roughness, and sensitivity in photomask production by electron beam lithography

Theoretical study on protected unit fluctuation of chemically amplified resists used for photomask production by electron beam lithography

Theoretical study on effects of electron thermal energy on sensitization process of chemically amplified electron beam resists-contribution to resist heating effect in electron beam mask writing

Analysis of mitigating factors for line edge roughness generated during electron beam lithography using machine learning

Resist thickness dependence of line width roughness of chemically amplified resists used for electron beam lithography

Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection

Theoretical study on effects of exposure pattern width on line edge roughness and stochastic defect generation in fabrication of 16-nm-half-pitch line-and-space patterns by electron beam lithography

Heating effect of the radiation chemistry of polyhydroxystyrene-type chemically amplified resists

Comparison of S-1–cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials

Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan

Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)

Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701

Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study

Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells

Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing

A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma

A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data

Suchergebnisse filtern